The Efficacy and Safety of Liraglutide 3.0 mg for Weight Management in Obese Non-Diabetic Saudi Outpatients

BACKGROUND: Unmanaged cases of obesity might lead to serious conditions and complications, which impair patients’ lives. The aim of this study was to assess the effectiveness and safety of daily 3 mg subcutaneous (s/c) Liraglutide amongst obese non-diabetic patients in Eastern Province, Saudi Arabia...

Descripción completa

Detalles Bibliográficos
Autores principales: Albaker, Waleed, Al Sheikh, Mona, Albakr, Aishah, Alkhafaji, Dania, Al Besher, Eman, Al-Hariri, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627262/
https://www.ncbi.nlm.nih.gov/pubmed/34849008
http://dx.doi.org/10.2147/IJGM.S336904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627262/
https://www.ncbi.nlm.nih.gov/pubmed/34849008
http://dx.doi.org/10.2147/IJGM.S336904

Ejemplares similares